Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102


Mannose Receptor-positive Macrophage Infiltration Correlates with Prostate Cancer Onset and Metastatic Castration-resistant Disease.

Zarif JC, Baena-Del Valle JA, Hicks JL, Heaphy CM, Vidal I, Luo J, Lotan TL, Hooper JE, Isaacs WB, Pienta KJ, De Marzo AM.

Eur Urol Oncol. 2019 Jul;2(4):429-436. doi: 10.1016/j.euo.2018.09.014. Epub 2018 Oct 19.


The Identification of Macrophage-enriched Glycoproteins Using Glycoproteomics.

Zarif JC, Yang W, Hernandez JR, Zhang H, Pienta KJ.

Mol Cell Proteomics. 2017 Jun;16(6):1029-1037. doi: 10.1074/mcp.M116.064444. Epub 2017 Mar 27.


Jagged1 promotes aromatase inhibitor resistance by modulating tumor-associated macrophage differentiation in breast cancer patients.

Liu H, Wang J, Zhang M, Xuan Q, Wang Z, Lian X, Zhang Q.

Breast Cancer Res Treat. 2017 Nov;166(1):95-107. doi: 10.1007/s10549-017-4394-2. Epub 2017 Jul 20.


PKCζ in prostate cancer cells represses the recruitment and M2 polarization of macrophages in the prostate cancer microenvironment.

Fan HH, Li L, Zhang YM, Yang J, Li MC, Zeng FY, Deng F.

Tumour Biol. 2017 Jun;39(6):1010428317701442. doi: 10.1177/1010428317701442.


Noninvasive Imaging of CD206-Positive M2 Macrophages as an Early Biomarker for Post-Chemotherapy Tumor Relapse and Lymph Node Metastasis.

Zhang C, Yu X, Gao L, Zhao Y, Lai J, Lu D, Bao R, Jia B, Zhong L, Wang F, Liu Z.

Theranostics. 2017 Sep 26;7(17):4276-4288. doi: 10.7150/thno.20999. eCollection 2017.


Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response.

Ylitalo EB, Thysell E, Jernberg E, Lundholm M, Crnalic S, Egevad L, Stattin P, Widmark A, Bergh A, Wikström P.

Eur Urol. 2017 May;71(5):776-787. doi: 10.1016/j.eururo.2016.07.033. Epub 2016 Aug 3.


Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castration-naïve Prostate Cancer in the GETUG-AFU 15 Phase 3 Trial.

Lavaud P, Gravis G, Foulon S, Joly F, Oudard S, Priou F, Latorzeff I, Mourey L, Soulié M, Delva R, Krakowski I, Laguerre B, Théodore C, Ferrero JM, Beuzeboc P, Habibian M, Rolland F, Deplanque G, Pouessel D, Zanetta S, Berdah JF, Dauba J, Baciuchka M, Platini C, Linassier C, Tubiana-Mathieu N, Machiels JP, Kouri CE, Ravaud A, Suc E, Eymard JC, Hasbini A, Bousquet G, Culine S, Boher JM, Tergemina-Clain G, Legoupil C, Fizazi K.

Eur Urol. 2018 May;73(5):696-703. doi: 10.1016/j.eururo.2017.09.022. Epub 2017 Oct 23.


Macrophage type 2 differentiation in a patient with laryngeal squamous cell carcinoma and metastatic prostate adenocarcinoma to the cervical lymph nodes.

Topf MC, Tuluc M, Harshyne LA, Luginbuhl A.

J Immunother Cancer. 2017 Jul 18;5(1):60. doi: 10.1186/s40425-017-0264-z.


M2-polarized tumor-associated macrophage infiltration of regional lymph nodes is associated with nodal lymphangiogenesis and occult nodal involvement in pN0 pancreatic cancer.

Kurahara H, Takao S, Maemura K, Mataki Y, Kuwahata T, Maeda K, Sakoda M, Iino S, Ishigami S, Ueno S, Shinchi H, Natsugoe S.

Pancreas. 2013 Jan;42(1):155-9. doi: 10.1097/MPA.0b013e318254f2d1.


Human breast cancer cells educate macrophages toward the M2 activation status.

Sousa S, Brion R, Lintunen M, Kronqvist P, Sandholm J, Mönkkönen J, Kellokumpu-Lehtinen PL, Lauttia S, Tynninen O, Joensuu H, Heymann D, Määttä JA.

Breast Cancer Res. 2015 Aug 5;17:101. doi: 10.1186/s13058-015-0621-0.


Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.

Li H, Huang N, Zhu W, Wu J, Yang X, Teng W, Tian J, Fang Z, Luo Y, Chen M, Li Y.

BMC Cancer. 2018 May 22;18(1):579. doi: 10.1186/s12885-018-4299-4.


Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry.

Rakaee M, Busund LR, Jamaly S, Paulsen EE, Richardsen E, Andersen S, Al-Saad S, Bremnes RM, Donnem T, Kilvaer TK.

Neoplasia. 2019 Mar;21(3):282-293. doi: 10.1016/j.neo.2019.01.005. Epub 2019 Feb 10.


Effects of eicosapentaenoic acid and docosahexaenoic acid on prostate cancer cell migration and invasion induced by tumor-associated macrophages.

Li CC, Hou YC, Yeh CL, Yeh SL.

PLoS One. 2014 Jun 12;9(6):e99630. doi: 10.1371/journal.pone.0099630. eCollection 2014. Retraction in: PLoS One. 2017 Feb 28;12 (2):e0173325.


Novel Junction-specific and Quantifiable In Situ Detection of AR-V7 and its Clinical Correlates in Metastatic Castration-resistant Prostate Cancer.

Zhu Y, Sharp A, Anderson CM, Silberstein JL, Taylor M, Lu C, Zhao P, De Marzo AM, Antonarakis ES, Wang M, Wu X, Luo Y, Su N, Nava Rodrigues D, Figueiredo I, Welti J, Park E, Ma XJ, Coleman I, Morrissey C, Plymate SR, Nelson PS, de Bono JS, Luo J.

Eur Urol. 2018 May;73(5):727-735. doi: 10.1016/j.eururo.2017.08.009. Epub 2017 Sep 1.


SPHK2 protein expression, Ki-67 index and infiltration of tumor-associated macrophages (TAMs) in human glioma.

Liu J, Zhou Q, Wu CP, Xu YW, Liu WL, Zhao HF, Li WP.

Histol Histopathol. 2018 Sep;33(9):987-994. doi: 10.14670/HH-11-995. Epub 2018 Apr 26.


Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.

Qian Y, Qiao S, Dai Y, Xu G, Dai B, Lu L, Yu X, Luo Q, Zhang Z.

ACS Nano. 2017 Sep 26;11(9):9536-9549. doi: 10.1021/acsnano.7b05465. Epub 2017 Sep 6.


Molecular characterization of enzalutamide-treated bone metastatic castration-resistant prostate cancer.

Efstathiou E, Titus M, Wen S, Hoang A, Karlou M, Ashe R, Tu SM, Aparicio A, Troncoso P, Mohler J, Logothetis CJ.

Eur Urol. 2015 Jan;67(1):53-60. doi: 10.1016/j.eururo.2014.05.005. Epub 2014 May 29.


A Review of Preclinical Experiments Toward Targeting M2 Macrophages in Prostate Cancer.

Seif F, Sharifi L, Khoshmirsafa M, Mojibi Y, Mohsenzadegan M.

Curr Drug Targets. 2019;20(7):789-798. doi: 10.2174/1389450120666190123141553.


Infiltration of diametrically polarized macrophages predicts overall survival of patients with gastric cancer after surgical resection.

Zhang H, Wang X, Shen Z, Xu J, Qin J, Sun Y.

Gastric Cancer. 2015 Oct;18(4):740-50. doi: 10.1007/s10120-014-0422-7. Epub 2014 Sep 18.


CD86⁺/CD206⁺, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient Prognosis.

Dong P, Ma L, Liu L, Zhao G, Zhang S, Dong L, Xue R, Chen S.

Int J Mol Sci. 2016 Mar 1;17(3):320. doi: 10.3390/ijms17030320.

Supplemental Content

Support Center